Hyoun Sc, Obican SG, Scialli AR: Teratogen update: methotrexate. Birth Defects Res A Clin Mol TeratoIs94(4):187, 2012
Iahnaccone PM, Bossert NL, Connelly CS: Disruption of embryonic and fetal development due to preimplantation chemical insults: a critical review. Am ] Obstet Gynecol 157(2):476, 1987
Jasper ]D, Goel R, Einarson A, et al: Efects of framing on teratogenic risk perception in pregnant women. Lancet 358(9289): 1237, 2001
Jones KL, Smith DW, Ulleland CN, et al: Pattern of malformation in ofspring of chronic alcoholic mothers. Lancet 1 (7815): 1267, 1973
Jordan AE, Jackson GL, Deardorf D, et al: Serotonin reuptake inhibitor use in pregnancy and the neonatal behavioral syndrome. ] Matern Fetal Neonatal Med 21(10):745,s2008
Jubilant DraxImage: HICON (Sodium Iodine 131) prescribing information, 2016. Available at: http://www.draximage.com/wp-content/ uploads/2016/111HICON-prod-ins-US.pdf. Accessed September 24,s2017
Kaplan YC, Ozsarfati], Etwel F, et al: Pregnancy outcomes following irst-trimester exposure to topical retinoids: a systematic review and meta-analysis. Br] Dernutol 173(5): 1117, 2015
Khoury M], James LM, Flanders WD, et al: Interpretation of recurring weak association obtained from epidemiologic studies of suspected human teratogens. Teratology 46(1):69, 1992
Kieler H, Artama M, Engeland A, et al: Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the ive Nordic countries. BM] 344:d8012, 2012
King RW, Baca M], Armenti VT, et al: Pregnancy outcomes related to mycophenolate exposure in female kidney transplant recipients. Ams] Transplant 17(1):151,s2017
Kirshon B, Wasserstrum N, Willis R, et al: Teratogenic efects of irst trimester cyclophosphamide therapy. Obstet Gynecol 72(3Pt2):462, 1988
Klarskov P, Andersen ]T, Jimenez-Solem E, et al: Short-acting sulfonamides near term and neonatal jaundice. Obstet Gynecolsl22(1):105, 2013
Klip H, Verloop], van Gool ]D, et al: Hypospadias in sons of women exposed to diethylstilbestrol in utero: a cohort study. Lancet 359(9312): 11 02, 2002
Koren G, Bologa M, Long D, et al: Perception of teratogenic risk by pregnant women exposed to drugs and chemicals during the irst trimester. Am ] Obstet GynecoIs160(5Ptl):1190, 1989
Koren G, Florescu A, Costei AM, et al: Nonsteroidal anti-inflammatory drugs during third trimester and the risk of premature closure of the ductus arteriosus: a meta-analysis. Ann Pharmacother 40(5):824, 2006